159 related articles for article (PubMed ID: 18794142)
1. Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer.
Hermans KG; van der Korput HA; van Marion R; van de Wijngaart DJ; Ziel-van der Made A; Dits NF; Boormans JL; van der Kwast TH; van Dekken H; Bangma CH; Korsten H; Kraaij R; Jenster G; Trapman J
Cancer Res; 2008 Sep; 68(18):7541-9. PubMed ID: 18794142
[TBL] [Abstract][Full Text] [Related]
2. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer.
Winnes M; Lissbrant E; Damber JE; Stenman G
Oncol Rep; 2007 May; 17(5):1033-6. PubMed ID: 17390040
[TBL] [Abstract][Full Text] [Related]
4. c-Jun has multiple enhancing activities in the novel cross talk between the androgen receptor and Ets variant gene 1 in prostate cancer.
Cai C; Hsieh CL; Shemshedini L
Mol Cancer Res; 2007 Jul; 5(7):725-35. PubMed ID: 17634427
[TBL] [Abstract][Full Text] [Related]
5. Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer.
Hermans KG; Bressers AA; van der Korput HA; Dits NF; Jenster G; Trapman J
Cancer Res; 2008 May; 68(9):3094-8. PubMed ID: 18451133
[TBL] [Abstract][Full Text] [Related]
6. [Frequency and transcript variant analysis of gene fusions between TMPRSS2 and ETS transcription factor genes in prostate cancer].
Dai MJ; Chen LL; Zheng YB; Chen W; Tao ZH; Weng ZL; Wu XL; Li CD; Chen ZG; Chen XD; Shi SB
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(10):669-73. PubMed ID: 18642766
[TBL] [Abstract][Full Text] [Related]
7. Androgen regulation of ETS gene fusion transcripts in prostate cancer.
Gasi D; Trapman J
Methods Mol Biol; 2011; 776():335-48. PubMed ID: 21796535
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of full-length ETV1 transcripts in clinical prostate cancer due to gene translocation.
Gasi D; van der Korput HA; Douben HC; de Klein A; de Ridder CM; van Weerden WM; Trapman J
PLoS One; 2011 Jan; 6(1):e16332. PubMed ID: 21298110
[TBL] [Abstract][Full Text] [Related]
9. ETV1 is a novel androgen receptor-regulated gene that mediates prostate cancer cell invasion.
Cai C; Hsieh CL; Omwancha J; Zheng Z; Chen SY; Baert JL; Shemshedini L
Mol Endocrinol; 2007 Aug; 21(8):1835-46. PubMed ID: 17505060
[TBL] [Abstract][Full Text] [Related]
10. Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer.
Wang J; Cai Y; Ren C; Ittmann M
Cancer Res; 2006 Sep; 66(17):8347-51. PubMed ID: 16951141
[TBL] [Abstract][Full Text] [Related]
11. Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.
Helgeson BE; Tomlins SA; Shah N; Laxman B; Cao Q; Prensner JR; Cao X; Singla N; Montie JE; Varambally S; Mehra R; Chinnaiyan AM
Cancer Res; 2008 Jan; 68(1):73-80. PubMed ID: 18172298
[TBL] [Abstract][Full Text] [Related]
12. Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts.
Mesquita D; Barros-Silva JD; Santos J; Skotheim RI; Lothe RA; Paulo P; Teixeira MR
Oncotarget; 2015 Mar; 6(7):5217-36. PubMed ID: 25595908
[TBL] [Abstract][Full Text] [Related]
13. Purine-rich element binding protein (PUR) alpha induces endoplasmic reticulum stress response, and cell differentiation pathways in prostate cancer cells.
Inoue T; Maeno A; Talbot C; Zeng Y; Yeater DB; Leman ES; Kulkarni P; Ogawa O; Getzenberg RH
Prostate; 2009 Jun; 69(8):861-73. PubMed ID: 19267365
[TBL] [Abstract][Full Text] [Related]
14. Novel 5' fusion partners of ETV1 and ETV4 in prostate cancer.
Barros-Silva JD; Paulo P; Bakken AC; Cerveira N; Løvf M; Henrique R; Jerónimo C; Lothe RA; Skotheim RI; Teixeira MR
Neoplasia; 2013 Jul; 15(7):720-6. PubMed ID: 23814484
[TBL] [Abstract][Full Text] [Related]
15. The association of Id-1, MIF and GSTpi with acquired drug resistance in hormone independent prostate cancer cells.
Lin JC; Chang SY; Hsieh DS; Lee CF; Yu DS
Oncol Rep; 2005 May; 13(5):983-8. PubMed ID: 15809768
[TBL] [Abstract][Full Text] [Related]
16. Carboxyl-terminal repressor domain of MBP-1 is sufficient for regression of prostate tumor growth in nude mice.
Ghosh AK; Steele R; Ray RB
Cancer Res; 2005 Feb; 65(3):718-21. PubMed ID: 15705866
[TBL] [Abstract][Full Text] [Related]
17. Novel expressed sequences identified in a model of androgen independent prostate cancer.
Quayle SN; Hare H; Delaney AD; Hirst M; Hwang D; Schein JE; Jones SJ; Marra MA; Sadar MD
BMC Genomics; 2007 Jan; 8():32. PubMed ID: 17257419
[TBL] [Abstract][Full Text] [Related]
18. miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.
Gandellini P; Folini M; Longoni N; Pennati M; Binda M; Colecchia M; Salvioni R; Supino R; Moretti R; Limonta P; Valdagni R; Daidone MG; Zaffaroni N
Cancer Res; 2009 Mar; 69(6):2287-95. PubMed ID: 19244118
[TBL] [Abstract][Full Text] [Related]
19. TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer.
Tomlins SA; Mehra R; Rhodes DR; Smith LR; Roulston D; Helgeson BE; Cao X; Wei JT; Rubin MA; Shah RB; Chinnaiyan AM
Cancer Res; 2006 Apr; 66(7):3396-400. PubMed ID: 16585160
[TBL] [Abstract][Full Text] [Related]
20. PrLZ expression is associated with the progression of prostate cancer LNCaP cells.
Li L; Zhang D; Zhang L; Zhu G; Sun Y; Wu K; Wang X; He D
Mol Carcinog; 2009 May; 48(5):432-40. PubMed ID: 18800346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]